Genetic Contribution of Polymorphisms in Glutathione S-Transferases to Brain Tumor Risk.
Existing data have shown a major effect of glutathione S-transferase (GST) single-nucleotide polymorphisms on activities of detoxification-related enzymes, and it is the functional importance that leads to extensive research on the association of GST polymorphisms with the risk of developing brain tumor. Previously reported associations, nevertheless, remain inconsistent. This study aimed to reevaluate the association with new information from recent research articles. We weekly searched multiple databases, aiming to cover all studies looking at the associations being examined in this work. Eligibility of studies was evaluated based on predesigned inclusion criteria. To assess the association of GST polymorphisms with brain tumor risk, we calculated genotypic ORs by comparing the number of genotypes between cases and controls. We also detected interstudy heterogeneity, publication bias, and single studies' influence. A total of 13 research articles were identified through databases and hand search. We found significantly elevated risk of brain tumor associated with GSTT1 null status in individuals of European ethnicity (OR 1.46, 95% CI 1.12-1.92). In the analysis of GSTP1 I105V, we observed that Val/Val genotype compared to the Ile/Ile genotype was more prone to a reduced brain tumor risk (OR 0.77, 95% CI 0.64-0.93). Such major effects were similarly seen for GSTP1 A114V (OR 1.14, 95% CI 1.01-1.29 for Val/Val + Ala/Val vs. Ala/Ala). When data were limited to glioma, we found a significant elevation associated with the combination of Val/Val and Ala/Val genotypes (OR 1.18, 95% CI 1.01-1.37). However, no clear association was detected between other polymorphisms investigated and glioma. These statistical data suggest that some of the polymorphisms at GST loci are possibly associated with the genetic risk of brain tumor.
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Peiliang
P
Geng
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Jianjun
J
Li
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Ning
N
Wang
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Juanjuan
J
Ou
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Ganfeng
G
Xie
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Rina
R
Sa
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Chen
C
Liu
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Lisha
L
Xiang
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China.
Hongtao
H
Li
Department of Oncology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, 29 Gaotanyan Main Street, Chongqing, 400038, China. lianghoujie@sina.com.
Houjie
H
Liang
D001932:Brain Neoplasms / Q000201:enzymology* / Q000235:genetics*; D018740:Genetic Heterogeneity; D020022:Genetic Predisposition to Disease; D005982:Glutathione Transferase / Q000235:genetics*; D006801:Humans; D008957:Models, Genetic; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012307:Risk Factors
D005982:Glutathione Transferase
Brain tumor; Genetic risk; Glutathione S-transferase; Polymorphism